Tag Archive | "discusses-latest"

Lead Researcher Discusses Latest Pertuzumab Data in HER2+ Breast Cancer – OncLive

August 12, 2017 No comments yet

OncLive Lead Researcher Discusses Latest Pertuzumab Data in HER2+ Breast Cancer OncLive Results from the phase III APHINITY trial showed that adding pertuzumab (Perjeta) to standard postoperative trastuzumab (Herceptin) therapy in patients with HER2-positive early breast cancer improved the rate of recurrence overall, but had a greater …